Anjoh, Japan

Hideaki Inagaki


Average Co-Inventor Count = 13.5

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • Inabe, JP (2005)
  • Anjoh, JP (2003 - 2007)

Company Filing History:


Years Active: 2003-2007

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Hideaki Inagaki

Introduction

Hideaki Inagaki is a notable inventor based in Anjoh, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target inflammatory and autoimmune diseases. With a total of seven patents to his name, Inagaki's work has the potential to impact many lives.

Latest Patents

Inagaki's latest patents include innovative compounds that act as antagonists of Monocyte Chemoattractant Protein-1 (MCP-1) function. These compounds are designed for the prevention or treatment of various chronic or acute inflammatory and autoimmune diseases. Conditions such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, Crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis, and transplant rejection are specifically targeted by these pharmaceutical compositions. The methods of treatment and processes for preparing these compounds are also detailed in his patents.

Career Highlights

Throughout his career, Inagaki has worked with reputable companies such as Telik, Inc. and Sanwa Kagaku Kenkyusho Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

Inagaki has collaborated with professionals like Edgardo Laborde and Louise Robinson. These partnerships have likely enhanced his research and innovation efforts.

Conclusion

Hideaki Inagaki's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to addressing significant health challenges. His work continues to pave the way for advancements in the treatment of inflammatory and autoimmune diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…